PMC:7600245 / 116-548
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T2 | 19-43 | Disease | denotes | coronavirus disease-2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 45-53 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 140-154 | Chemical | denotes | pharmaceutical | http://purl.obolibrary.org/obo/CHEBI_52217 |
| T2 | 323-333 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T3 | 338-351 | Chemical | denotes | dexamethasone | http://purl.obolibrary.org/obo/CHEBI_41879 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 6-14 | Sentence | denotes | Abstract |
| T4 | 15-124 | Sentence | denotes | The coronavirus disease-2019 (COVID-19) pandemic continues to challenge health care systems around the world. |
| T5 | 125-269 | Sentence | denotes | Scientists and pharmaceutical companies have promptly responded by advancing potential therapeutics into clinical trials at an exponential rate. |
| T6 | 270-352 | Sentence | denotes | Initial encouraging results have been realized using remdesivir and dexamethasone. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 18 | 323-333 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 19 | 338-351 | Chemical | denotes | dexamethasone | MESH:D003907 |
| 20 | 19-43 | Disease | denotes | coronavirus disease-2019 | MESH:C000657245 |
| 21 | 45-53 | Disease | denotes | COVID-19 | MESH:C000657245 |